SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function is a research paper published in Inflammation (2021). On theSindex it has a DataRank of 0.470. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI125640
National Institutes of Health
Grant: CA231277
National Institutes of Health
Grant: AI150597
Cancer Research Institute
Grant: N/A
NIAID NIH HHS
Grant: R01 AI125640
NCI NIH HHS
Grant: R21 CA231277
NIAID NIH HHS
Grant: R01 AI150597
National Institutes of Health
Grant: 5R01AI125640-09
Novel mechanisms regulating PD-1 signaling and function
National Institutes of Health
Grant: 1R21CA231277-01A1
(PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade
National Institutes of Health
Grant: 5R01AI150597-04
PAG is a novel target in immunotherapy
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals